A. Pannocchia et al., REVERSAL OF DOXORUBICIN RESISTANCE BY THE AMILORIDE ANALOG EIPA IN MULTIDRUG-RESISTANT HUMAN COLON-CARCINOMA CELLS, Cell biochemistry and function, 14(1), 1996, pp. 11-18
Although multidrug resistance (mdr) may arise through a variety of mec
hanisms, the most widely studied and accepted form is associated with
an increased concentration of P-glycoprotein (P-gp), a 170 kd protein
found in the membrane fraction of a number of mammalian cells. Since m
di seems to be related to the ability of resistant cells to extrude dr
ugs and the circumvention of mdr is supposed to be due to the restored
ability to accumulate drugs, membrane has been regarded as the crucia
l site for such a regulation and an important role for membrane ion ex
changers has been suggested. The aim of this work was to elucidate whe
ther the Na+/H+ antiporter is involved in the mechanism of regulation
and circumvention of mdr and if 5-(N-ethyl-N-isopropyl) amiloride (EIP
A), a selective inhibitor of the Na+/H+ exchanger, can modulate the fu
nctional expression of the mdr phenotype. The effect of EIPA on doxoru
bicin (DX) resistant cells (LoVo/DX) obtained from a human colon adeno
carcinoma cell line (LoVo) was studied. EIPA at concentrations ranging
from 10 to 50 mu M was able to increase the antibiotic cytotoxicity i
n the resistant Lovo/DX cells. The reversal of DX resistance parallele
d an increase of the ability of the cells to accumulate the drug. Both
drug loading and sensitivity to the inhibitory effect of DX on cell p
roliferation were restored by EIPA in a dose-dependent way. These resu
lts suggest a new mechanism of mdr reversal and indicate that amilorid
e and its derivatives may be useful in reversing DX resistance and in
enhancing the clinical effectiveness of chemotherapeutics.